W
ONC

WealthCollab’s BeOne Medicines Ltd ONC Stock Holding History

WealthCollab’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71K Sell
6
-5
-45% -$1.47K ﹤0.01% 872
2026
Q1 		$3.27K Hold
11
– – ﹤0.01% 768
2025
Q4 		$3.34K Hold
11
– – ﹤0.01% 804
2025
Q3 		$3.75K Hold
11
– – ﹤0.01% 730
2025
Q2 		$2.66K Buy
+11
New +$2.7K ﹤0.01% 771

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

WealthCollab's ONC Position: Q2 2026 in Review

WealthCollab reduced its BeOne Medicines Ltd (ONC) stake by 45% in Q2 2026, selling an estimated $1.47K and leaving 6 shares worth $1.71K. The position accounts for ﹤0.01% of the portfolio, ranked #872.

WealthCollab first reported a position in ONC in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.75K in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • WealthCollab held 6 shares of BeOne Medicines Ltd worth $1.71K as of Q2 2026.
  • WealthCollab sold 5 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.47K.
  • BeOne Medicines Ltd made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #872 holding.
  • WealthCollab first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 5 quarters since.
  • WealthCollab's BeOne Medicines Ltd position peaked at $3.75K in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.